Bioresorbable Coronary Stents Market to Grow with a CAGR of 10.25% through 2030
Rising Prevalence of Cardiovascular Diseases (CVDs) and Rising Patient Preference for Minimally Invasive Procedures are factors driving the Global Bioresorbable Coronary Stents Market in the forecast period 2026-2030
According to TechSci Research report, “Bioresorbable
Coronary Stents Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2030F”, the Global Bioresorbable Coronary
Stents Market stood at USD 550.09 Million in 2024 and is anticipated to grow
with a CAGR of 10.25% in the forecast period, 2026-2030.
Bioresorbable stents are emerging as a superior alternative to conventional metallic drug-eluting stents (DES), offering distinct clinical advantages that drive their increasing adoption among cardiologists and patients. A key benefit is the reduced risk of late stent thrombosis, as these stents gradually dissolve, minimizing long-term complications such as clot formation. Additionally, bioresorbable stents restore natural vessel function, allowing arteries to regain flexibility and movement post-treatment—an advantage not available with permanent implants. The elimination of foreign material over time also leads to lower risks of inflammation and restenosis, contributing to better long-term patient outcomes.
Technological advancements and ongoing research and development (R&D) efforts are further propelling the bioresorbable stent market. Innovations in stent design, polymer coatings, and drug-elution mechanisms have resulted in improved degradation rates and mechanical strength. New materials, such as poly-L-lactic acid (PLLA) and magnesium-based stents, are being developed to enhance performance, while advancements like thinner struts, optimized resorption timelines, and improved drug-release profiles are increasing clinical efficacy. Regulatory agencies, including the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and China’s National Medical Products Administration (NMPA), are actively assessing and approving these technologies, further accelerating market adoption. Favorable reimbursement policies and increased funding for cardiovascular research have also contributed to market expansion. Growing awareness among healthcare professionals about the long-term benefits of bioresorbable coronary stents is driving their incorporation into standard treatment protocols, particularly for younger patients and those at high risk of complications from permanent implants.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Bioresorbable Coronary Stents Market”
The Global Bioresorbable Coronary Stents Market is
segmented into Brand,
End User, regional distribution and company.
Based
on its brand, MeRes-100 segment emerged as the dominant segment in the global market for Bioresorbable Coronary Stents in 2024. MeRes-100 is made from a biocompatible polymer called PLLA (Poly-L-Lactic Acid), which has a long history of safe use in medicine. This material gradually dissolves in the body over time, eliminating the need for a permanent implant. After implantation, the MeRes-100 stent provides support to the artery during the initial healing period. As the PLLA gradually breaks down, it allows the artery to regain its natural flexibility and function. This process typically takes about two to three years. Unlike metallic stents, which can remain in the body indefinitely, MeRes-100 minimizes the risk of long-term complications such as inflammation, thrombosis, and restenosis. Patients may require a shorter duration of dual antiplatelet therapy, reducing the burden of medication. MeRes-100 is designed with advanced features to aid in its deployment and post-implantation assessment. Radiopaque markers help physicians precisely position the stent, while the stent's thinner struts provide improved visibility on imaging tests, ensuring proper placement and apposition. The MeRes-100 stent has received regulatory approvals in various countries, making it accessible to a broader range of patients around the world. Clinical studies have shown promising results for the MeRes-100 stent. Patients who received this bioresorbable stent experienced comparable clinical outcomes to those who received traditional metallic stents. Moreover, the reduced need for long-term antiplatelet therapy and the avoidance of potential complications associated with permanent implants make it an appealing choice for both patients and physicians.
Based on region, The Asia Pacific region is experiencing rapid market
growth. Clinical research and academic institutions in Asia Pacific have been
active in conducting clinical trials to generate evidence supporting the safety
and efficacy of bioresorbable coronary stents. This evidence helps in gaining
acceptance among healthcare providers and insurers.
Major companies operating in
Global Bioresorbable Coronary Stents Market are:
- BIOTRONIK SE & Co. KG
- Meril Life Sciences Pvt. Ltd
- Elixir Medical Corporation.
- Reva Medical, LLC
- Terumo Corporation
- Lepu Medical Technology (Beijing)Co.,Ltd
- MicroPort Scientific Corporation
- LifeTech Scientific Corporation
- Boston Scientific Corporation
- Medtronic plc
Download Free Sample Report
Customers can also request 10% free
customization in this report.
“The Bioresorbable Coronary Stents Market is poised
for significant growth, driven by a confluence of factors that include the
rising prevalence of CAD, technological advancements, a favorable regulatory
environment, patient preferences, increased healthcare spending, and
collaborative efforts within the industry. As these drivers continue to propel
innovation and market expansion, bioresorbable coronary stents are likely to
become a standard of care in the treatment of coronary artery disease, offering
improved patient outcomes and a brighter future for cardiology patients
worldwide.,” said Mr. Karan Chechi, Research Director of TechSci Research, a
research-based management consulting firm.
“Bioresorbable Coronary Stents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Brand (Magmaris, Magnitude, MeRes-100, DESolve, Others), By End User (Hospitals & Clinics, Ambulatory Care Centers, Others), By Region & Competition, 2020-2030F”, has evaluated the future growth potential of Global
Bioresorbable Coronary Stents Market and provides statistics & information
on market size, structure and future market growth. The report intends to
provide cutting-edge market intelligence and help decision makers take sound
investment decisions. Besides, the report also identifies and analyzes the
emerging trends along with essential drivers, challenges, and opportunities in
Global Bioresorbable Coronary Stents Market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: sales@techsciresearch.com
Website: www.techsciresearch.com